Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Susan D. Hellmann0
Date of Patent
February 4, 2014
0Patent Application Number
109099980
Date Filed
August 2, 2004
0Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention concerns the treatment of disorders characterized by the overexpression of ErbB2. More specifically, the invention concerns the treatment of human patients susceptible to or diagnosed with cancer overexpressing ErbB2 with a combination of an anti-ErbB2 antibody and a chemotherapeutic agent other than an anthracycline, e.g. doxorubicin or epirubicin. The invention further provides a method of treating cancer in a human patient comprising administering effective amounts of an anti-ErbB2 antibody and a cardioprotectant to the patient.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
